Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 13, 2023

First-in-Patient Study of OTL78 for Intraoperative Fluorescence Imaging of PSMA-Positive Prostate Cancer

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial
Lancet Oncol 2023 Apr 13;[EPub Ahead of Print], JA Stibbe, HA de Barros, DGJ Linders, SS Bhairosingh, EM Bekers, PJ van Leeuwen, PS Low, SA Kularatne, AL Vahrmeijer, J Burggraaf, HG van der Poel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading